资讯

SA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year ...
Misinformation fuelled by US health czar Robert Kennedy Jr is creating a dangerous — and growing — lack of trust in vaccines.
A throat ulcer. Bloody urine. A sick baby. That’s what smokers in other countries see. In South Africa? For now, it’s a tiny ...
Today, people over 50 make up the second largest group of South Africa’s HIV-positive population. But as people age, health problems like high blood pressure, heart disease and diabetes rise too, ...
The Global Fund for HIV, TB and Malaria says it will fund the roll-out of the twice-yearly anti-HIV jab, lenacapavir, for poorer countries, including South Africa, with or without the help of the US ...
In today’s newsletter, Mia Malan explains how US President Donald Trump ordered USAID-funded HIV organisations in SA to shut down. Sign up for our newsletter today. Pepfar-funded HIV organisations in ...
Mia Malan is the founder and editor-in-chief of Bhekisisa. She has worked in newsrooms in Johannesburg, Nairobi and Washington, DC, winning more than 30 awards for her radio, print and television work ...
Speed, scale and price would sway whether the drugmaker Gilead’s twice-a-year anti-HIV jab, lenacapavir, will be able to markedly slow down new infections in South Africa. What needs to happen for SA ...
The health department says ViiV Healthcare’s non-profit price for their anti-HIV jab, CAB-LA, is four times what it can pay. In 2022, just over 164 200 people in South Africa became newly infected ...
Laura Lopez Gonzalez is a freelance health journalist and editor. She was Bhekisisa's news editor, then deputy editor between 2016 and 2020.